ETF Movers on Tuesday: ARKF, XT
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 16 2025
0mins
Source: NASDAQ.COM
ETF Performance: The iShares Future Exponential Technologies ETF is underperforming, down approximately 7.9% in Tuesday afternoon trading.
Weakest Components: Key contributors to this decline include Pfizer, which fell by about 4.5%, and Guardant Health, which decreased by around 3.4%.
Market Context: The article highlights the performance of specific ETFs and their components, indicating broader market trends.
Author's Perspective: The views expressed in the article are those of the author and do not necessarily represent Nasdaq, Inc.
Analyst Views on ARKF
Wall Street analysts forecast ARKF stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ARKF is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 46.060
Low
Averages
High
Current: 46.060
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
